RNA therapeutics

RNA Therapeutics

RNA therapeutics (pronounced: R-N-A therapeutics) is a rapidly evolving field of medicine that uses RNA-based drugs to treat diseases.

Etymology

The term "RNA therapeutics" is derived from the abbreviation RNA, which stands for Ribonucleic Acid, and the word "therapeutics", which refers to the treatment of disease.

Definition

RNA therapeutics involves the use of RNA molecules as drugs to treat various diseases. These RNA molecules can either be small interfering RNAs (siRNA) or messenger RNAs (mRNA). The RNA molecules are designed to target specific genes in the body, thereby altering the expression of those genes and potentially treating the disease.

History

The concept of RNA therapeutics was first proposed in the late 20th century, following the discovery of RNA interference (RNAi). This discovery led to the development of siRNA-based drugs, which are designed to silence specific genes in the body. More recently, the field of RNA therapeutics has expanded to include mRNA-based drugs, which are designed to increase the expression of specific genes.

Applications

RNA therapeutics has potential applications in a wide range of diseases, including cancer, genetic disorders, infectious diseases, and autoimmune diseases. For example, RNA therapeutics is being used to develop vaccines for diseases such as COVID-19. In addition, RNA therapeutics is being explored as a potential treatment for genetic disorders such as cystic fibrosis and Duchenne muscular dystrophy.

Related Terms

External links

Medical encyclopedia article on RNA therapeutics
Wikipedia's article - RNA therapeutics

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

RNA therapeutics